▲ BUY
5
/ 10
Conviction
$ Value
$22K
Shares
1,000
Price
$22
Filed
Mar 12
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
BIENAIME JEAN JACQUES
Title
—
CIK
0001221590
Roles
Director
Transaction Details
Transaction Date
2026-03-10
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
37,415
Filing Info
BIENAIME JEAN JACQUES's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-15 | KROS | ▲ | $12K |
| 2026-03-11 | IMNM | ▲ | $22K |
| 2026-03-10 | IMNM | ▲ | $22K |
| 2026-03-09 | KROS | ▲ | $22K |
| 2025-06-10 | IMNM | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-10 | INCY | A | $0 |
| 2025-06-04 | KROS | A | $0 |
| 2025-06-04 | KROS | A | $0 |
| 2025-06-03 | IMNM | ▲ | $47K ★ |
Other Insiders at IMNM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SIEGALL CLAY B
President and CEO
|
$501K | — | 2026-03-27 |
| BIENAIME JEAN JACQUES | $22K | — | 2026-03-11 |
| WAGENHEIM PHILIP | — | $1.3M | 2026-03-23 |
|
Higgins Jack
Chief Scientific Officer
|
— | $204K | 2026-04-02 |
|
Rosett Max
Chief Financial Officer
|
— | $1.4M | 2026-04-02 |